Eighty-six asymptomatic IgAN patients (49 males and 37 females) were investigated; 82 of them were followed up during a mean +/- SD period of 66.7 +/- 19.7 months.
RESULTS: At biopsy, 18 patients (21%) presented with pure
hematuria (HU), 29 patients (34%) presented with
proteinuria alone (PU), and 39 patients (45%) presented concomitant
hematuria and
proteinuria with severe pathological lesions. Meanwhile, 16% and 26% had
renal insufficiency and
hypertension, respectively. Finally, urinary abnormalities of 15% of the patients disappeared, 25% of HU developed
proteinuria, 47% of concomitant
hematuria and
proteinuria, and 32% of PU appeared to have increase of
proteinuria, and 14% of PU developed
hematuria. Fifteen (24%) of the patients with normal blood pressure initially became hypertensive and 18 (22%) of the patients with normal renal function initially developed
renal insufficiency. Twenty-four patients (29%) had doubling of serum
creatinine level, and 13 patients (16%) progressed to
end-stage renal disease.
Prednisone therapy and
antihypertensive treatment significantly improved
proteinuria and renal function deterioration.
Hematuria,
hypertension during follow-up, and tubulointerstitial lesions were independent risk factors predictive of the ultimate development of renal progression.
CONCLUSIONS: The renal outcome of asymptomatic IgAN is guarded.
Hematuria,
hypertension during follow-up, and tubulointerstitial lesions may be important markers to monitor renal progression in the course.